Molecular Characterization of Extended-Spectrum Beta-Lactamase-Producing Escherichia coli from Community Fecal Samples in Sivas,Türkiye: Detection of the ST131 Clone
Restricted accessResearch articleFirst published online July, 2026
Molecular Characterization of Extended-Spectrum Beta-Lactamase-Producing Escherichia coli from Community Fecal Samples in Sivas,Türkiye: Detection of the ST131 Clone
This study aimed to determine beta-lactamase genes, clonal relationships, and the prevalence of the E.coli sequence type 131 (ST131) clone in extended-spectrum beta-lactamase (ESBL)-producing E.coli (ESBL-Ec) strains isolated from community fecal samples.
Methods:
A total of 161 fecal samples were collected from healthy individuals and outpatients at Sivas Cumhuriyet University Hospital. ESBL-Ec isolates obtained from these samples were analyzed. Antimicrobial susceptibility was determined by the disc diffusion method following EUCAST guidelines. The presence of blaTEM, blaSHV, blaCTX-M, blaOXA, blaPER, blaVEB, and blaGES genes was investigated by multiplex PCR. The ST131 clone was detected by PCR and Multi Locus Sequence Typing analyses. Clonal relatedness among ESBL-Ec strains was evaluated using ERIC-PCR.
Results:
The fecal ESBL-Ec carriage rate was 31.05%. Resistance rates to ciprofloxacin, trimethoprim-sulfamethoxazole, gentamicin, amikacin, and ertapenem were 38%, 58%, 14%, 6%, and 4%, respectively. ESBL genes were detected at rates of blaTEM 82%, blaCTX-M 68%, and blaOXA 10%. ESBL-Ec isolates were grouped into 15 clusters, and 5 (10%) of 50 isolates were identified as the ST131 clone.
Conclusion:
This first study in Sivas, Türkiye, shows a high fecal carriage rate of ESBL-Ec and the presence of the E.coli ST131 clone.
VilaJ, Sáez-LópezE, JohnsonJR, et al.Escherichia coli: An old friend with new tidings. FEMS Microbiol Rev2016;40(4):437–463; doi: 10.1093/femsre/fuw005
2.
PeiranoG, EndimianiA, PitoutJDD. CTX-M-producing Escherichia coli: History, molecular epidemiology and laboratory detection. Infect Drug Resist2025;18:6549–6560; doi: 10.2147/IDR.S553853
3.
KerekÁ, RománI, SzabóÁ, et al.Antibiotic resistance genes in Escherichia coli–literature review. Crit Rev Microbiol2026;52(1):1–35; doi: 10.1080/1040841X.2025.2492156
4.
BezabihYM, SabiitiW, AlamnehE, et al.The global prevalence and trend of human intestinal carriage of ESBL-producing Escherichia coli in the community. J Antimicrob Chemother2021;76(1):22–29; doi: 10.1093/jac/dkaa399
5.
CoqueTM, BaqueroF, CantonR. Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Eurosurveillance2008;13(47):1–11; doi: 10.2807/ese.13.47.19044-en
6.
CastanheiraM, SimnerPJ, BradfordPA. Extended-spectrum β-lactamases: An update on their characteristics, epidemiology and detection. JAC Antimicrob Resist2021;3(3):dlab092–d21; doi: 10.1093/jacamr/dlab092
7.
ValverdeA, GrillF, CoqueTM, et al.High rate of intestinal colonization with extended-spectrum-β-lactamase-producing organisms in household contacts of infected community patients. J Clin Microbiol2008;46(8):2796–2799; doi: 10.1128/JCM.01008-08
8.
WHO. Integrated Global Surveillance on ESBL-Producing E. coli Using a One Health Approach: Implementation and Opportunities. World Health Organization; 2021.
9.
European Union. Antimicrobial resistance surveillance in Europe 2023: 2021 data. Publications Office of the European Union; 2023.
10.
JousserandN, MassieraB, BordignonP-J, et al.A non-genotoxic variant of Escherichia coli Nissle 1917 EcN 2.0 overexpressing microcins reduces intestinal carriage of ST131 ESBL-producing Escherichia coli. Probiotics Antimicrob Proteins2025; doi: 10.1007/s12602-025-10777-y
MackowNA, ShaoW, GeL, Antibacterial Resistance Leadership Group. et al.; Escherichia coli ST131 drives carbapenem use for E. coli bloodstream infections. Clin Infect Dis2026:ciag160; doi: 10.1093/cid/ciag160
13.
ShropshireWC, SongX, BremerJ, et al.Comprehensive assessment of initial adaptation of extended-spectrum β-lactamase–positive ST131 Escherichia coli to carbapenem exposure. J Infect Dis2025;231(4):e685–e696; doi: 10.1093/infdis/jiae587
14.
Rodríguez-BañoJ, López-CereroL, NavarroMD, de AlbaPD, PascualA. Faecal carriage of extended-spectrum β-lactamase-producing Escherichia coli: Prevalence, risk factors and molecular epidemiology. J Antimicrob Chemother2008;62(5):1142–1149; doi: 10.1093/jac/dkn293
15.
El-BadawyMF, TawakolWM, MaghrabiIA, MansyMS, ShohayebMM, AshourMS. Iodometric and molecular detection of ESBL production among clinical ısolates of E. coli fingerprinted by ERIC-PCR: The first Egyptian report declares the emergence of E. coli O25b-ST131 clone harboring blaGES. Microb Drug Resist2017;23(6):703–717; doi: 10.1089/mdr.2016.0181
FangH, AtakerF, HedinG, DornbuschK. Molecular epidemiology of extended-spectrum β-lactamases among Escherichia coli isolates collected in a Swedish hospital and its associated health care facilities from 2001 to 2006. J Clin Microbiol2008;46(2):707–712; doi: 10.1128/JCM.01943-07
18.
DallenneC, da CostaA, DecréD, FavierC, ArletG. Development of a set of multiplex PCR assays for the detection of genes encoding important β-lactamases in Enterobacteriaceae. J Antimicrob Chemother2010;65(3):490–495; doi: 10.1093/jac/dkp498
19.
VersalovicJ, KoeuthT, LupskiR. Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes. Nucleic Acids Res1991;19(24):6823–6831; doi: 10.1093/nar/19.24.6823
20.
HungC, MarschallJ, BurnhamCAD, ByunAS, HendersonJP. The bacterial amyloid curli is associated with urinary source bloodstream infection. PLoS One2014;9(1):e86009–e6; doi: 10.1371/journal.pone.0086009
21.
DoumithM, DayM, CiesielczukH, et al.Rapid identification of major Escherichia coli sequence types causing urinary tract and bloodstream infections. J Clin Microbiol2015;53(1):160–166; doi: 10.1128/JCM.02562-14
22.
WirthT, FalushD, LanR, et al.Sex and virulence in Escherichia coli: An evolutionary perspective. Mol Microbiol2006;60(5):1136–1151; doi: 10.1111/j.1365-2958.2006.05172.x
Kurt AzapÖ, ArslanH, KaramanSÖ, ToganT. Risk factors for fecal carriage of extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella spp. in the community. Turk J Med Sci2007;37:31–38.
Çakir ErdoğanD, CömertF, AktaşE, KöktürkF, KülahC. Fecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. in a Turkish community. Turk J Med Sci2017;47(1):172–179; doi: 10.3906/sag-1512-9
27.
HazirolanG, MumcuogluI, AltanG, ÖzmenBB, AksuN, KarahanZC. Fecal carriage of extended-spectrum beta-lactamase and ampc beta-lactamase-producing Enterobacteriaceae in a Turkish community. Niger J Clin Pract2018;21(1):81–86; doi: 10.4103/njcp.njcp_79_17
28.
WuP-C, WangJ-L, HsuehP-R, et al.Prevalence and risk factors for colonization by extended-spectrum β-lactamase-producing or ST131 Escherichia coli among asymptomatic adults in community settings in Southern Taiwan. Infect Drug Resist2019;12:1063–1071; doi: 10.2147/IDR.S201086
29.
FriedmannR, RavehD, ZartzerE, et al.Prospective evaluation of colonization with extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae among patients at hospital admission and of subsequent colonization with ESBL-producing Enterobacteriaceae among patients during hospitalization. Infect Control Hosp Epidemiol2009;30(6):534–542; doi: 10.1086/597505
Ben‐AmiR, Rodríguez‐BañoJ, ArslanH, et al.A multinational survey of risk factors for infection with extended-spectrum β-lactamase-producing Enterobacteriaceae in nonhospitalized patients. Clın INFECT DIS2009;49(5):682–690; doi: 10.1086/604713
32.
SöğütlüN, CömertF, PişkinİE, AktaşE, KöktürkF, KülahC. Fecal carriage of extended spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella spp. in children in Zonguldak. FLORA2019;24(3):236–243; doi: 10.5578/flora.67966
33.
ChirindzeLM, ZimbaTF, SekyereJO, et al.Faecal colonization of E. coli and Klebsiella spp. producing. BMC Infect Dis2018;18:1–8; doi: 10.1186/s12879-018-3154-1
34.
YumukZ, AfacanG, Nicolas-ChanoineMH, SottoA, LavigneJP. Turkey: A further country concerned by community-acquired Escherichia coli clone O25-ST131 producing CTX-M-15. J Antimicrob Chemother2008;62(2):284–288; doi: 10.1093/jac/dkn181
CanF, Kurt-AzapÖ, İspirP, et al.The clinical impact of ST131 H30-Rx subclone in urinary tract infections due to multidrug-resistant Escherichia coli. J Glob Antimicrob Resist2016;4:49–52; doi: 10.1016/j.jgar.2015.10.006
37.
AktaşE, OtluB, ErdemirD, EkiciH, BulutE. A first insight into Escherichia coli ST131 high-risk clone among extended-spectrum beta-lactamase-producing urine isolates in Istanbul with the use of matrix-assisted laser desorption/ionization time-of-flight mass-spectrometry and real-time PCR. Microb Drug Resist2017;23(8):1032–1036; doi: 10.1089/mdr.2017.0021
38.
ÇizmeciZ, OtluB, AktaşE, ÖrdekçiS, AçikgözÖ, GüleçN. İdrar ve idrar dışı klinik örneklerden izole edilen GSBL üreten Escherichia coli izolatlarında yüksek riskli ST131 klonunun MALDI-TOF MS ve gerçek zamanlı PCR ile araştırılması. Mikrobiyol Bul2018;52(1):13–22; doi: 10.5578/mb.66475
39.
DemirciM, ÜnlüÖ, İstanbullu TosunA. Detection of O25b-ST131 clone, CTX-M-1 and CTX-M-15 genes via real-time PCR in Escherichia coli strains in patients with UTIs obtained from a university hospital in Istanbul. J Infect Public Health2019;12(5):640–644; doi: 10.1016/j.jiph.2019.02.017
40.
BulutME, HurkalG, DalgicN. Investigation of high-risk ST131 clone in extended spectrum β-lactamase-producing Escherichia coli isolates in children. J Pediatr Infect Dis2021;26:1–5; doi: 10.1055/s-0041-1730995
41.
European Centre for Disease Prevention and Control, World Health Organization. Antimicrobial resistance surveillance in Europe 2023: 2021 data. 2023.
42.
GozelMG, ElaldiN, KorgaliE, et al.Antimicrobial susceptibility and frequency of extended-spectrum beta-lactamase (ESBL) of Escherichia coli strains isolated from community-acquired and nosocomial infections. Flora2012;17(2):75–81.
43.
ArslanFM, PelitS, DalgicN, AktasES. Investigation of high-risk Escherichia coli ST131 clone carriage in healthy children. Rev Res Med Microbiol2026;37; doi: 10.1097/MRM.0000000000000450
44.
DhanjiH, DoumithM, ClermontO, et al.Real-time PCR for detection of the O25b-ST131 clone of Escherichia coli and its CTX-M-15-like extended-spectrum β-lactamases. Int J Antimicrob Agents2010;36(4):355–358; doi: 10.1016/j.ijantimicag.2010.06.007
45.
KocsisB, GulyásD, SzabóD. Emergence and dissemination of extraintestinal pathogenic high-risk international clones of Escherichia coli. Life (Basel)2022;12(12):2077; doi: 10.3390/life12122077
46.
García-MeniñoI, GarcíaV, MoraA, et al.Swine enteric colibacillosis in Spain: Pathogenic potential of mcr-1 ST10 and ST131 E. coli isolates. Front Microbiol2018;9:2659–2615; doi: 10.3389/fmicb.2018.02659
